Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amgen Inc (NASDAQ:AMGN)

185.76
Delayed Data
As of Sep 22
 -0.88 / -0.47%
Today’s Change
133.64
Today|||52-Week Range
191.10
+27.05%
Year-to-Date
4 Sell-Ranked Biotech Stocks with Falling Estimates to Avoid
Sep 21 / Zacks.com - Paid Partner Content
Is Amgen (AMGN) a Great Stock for Value Investors?
Sep 19 / Zacks.com - Paid Partner Content
Pfizer Sues J&J, Accuses it of Preventing Inflectra Uptake
Sep 21 / Zacks.com - Paid Partner Content
Novartis Announces Positive Data on Urticaria Drug Xolair
Sep 18 / Zacks.com - Paid Partner Content
Novartis Poised to Grow on Oncology Portfolio & Biosimilars
Sep 20 / Zacks.com - Paid Partner Content
Top Research Reports for Philip Morris, Amgen & Union Pacific
Sep 15 / Zacks.com - Paid Partner Content
Pfizer takes on J&J with antitrust lawsuit
Sep 20 / FT.com - Paid Partner Content
Amgen/Allergan's Avastin Biosimilar Secures FDA Approval
Sep 15 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: FDA Nod for First Cancer Biosimilar, HALO up on Deals, Raised ...
Sep 20 / Zacks.com - Paid Partner Content
Biosimilar 2017 Progress Report: Stocks in Focus
Sep 14 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close186.64
Today’s open185.48
Day’s range184.00 - 186.82
Volume2,275,630
Average volume (3 months)2,969,842
Market cap$135.5B
Dividend yield2.48%
Data as of 3:59pm ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)+13.02%
Earnings growth (this year)+7.82%
Earnings growth (next 5 years)+3.73%
Revenue growth (last year)+6.31%
P/E ratio16.9
Price/Sales4.86
Price/Book4.59

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences+0.65+0.79%
BIIBBiogen+3.43+1.09%
ILMNIllumina Inc+1.17+0.58%
KITEKite Pharma Inc-0.08-0.04%
Data as of 4:00pm ET, 09/22/2017

Financials

Next reporting dateOctober 24, 2017
EPS forecast (this quarter)$3.10
Annual revenue (last year)$22.7B
Annual profit (last year)$7.7B
Net profit margin34.04%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Esteban Santos
Corporate headquarters
Thousand Oaks, California

Forecasts